论文部分内容阅读
氨氯地平(amlodpine)是一种新的双氢毗院类钙站抗剂,结构类似硝苯院,但与后者不同,本品具有生物利用度高(60~65%)、吸收慢、终未半减期长(30~50小时)之特点。本文采用随机、双盲、平行试验比较了氨氯地平与依那普利治疗中、重度高血压的疗效和安全性。研究对象为31
Amlodpine is a new dihydroptergic calcium antagonist with a similar structure to nifedipine, but unlike the latter, amlodine has high bioavailability (60-65%), slow absorption, The final half-off period of long (30 to 50 hours) of the characteristics. In this paper, a randomized, double-blind, parallel test comparing amlodipine and enalapril treatment of moderate and severe hypertension efficacy and safety. The research object is 31